MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Personalis Total Non Current Liabilities 2011-2026 | PSNL
Annual Total Non Current Liabilities Personalis
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 639 K | 90.2 M | 77.2 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 90.2 M | 639 K | 56 M |
Total Non Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
61.1 M | $ 38.83 | 14.0 % | $ 442 M |  China |
 |
Brainsway Ltd.
BWAY
|
7.58 M | $ 23.3 | -0.34 % | $ 99.4 M |  Israel |
 |
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
2.76 M | $ 39.38 | -0.03 % | $ 1.09 B | USA |
 |
BioNano Genomics
BNGO
|
16.4 M | $ 1.26 | -2.69 % | $ 1.6 M | USA |
 |
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Exact Sciences Corporation
EXAS
|
981 M | $ 102.49 | 0.14 % | $ 19 B | USA |
 |
Co-Diagnostics
CODX
|
3.56 M | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
26.9 B | $ 222.92 | 1.85 % | $ 163 B | USA |
 |
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
559 K | - | - | $ 7.1 B |  Australia |
 |
Guardant Health
GH
|
91.4 M | $ 114.77 | 0.64 % | $ 14.1 B | USA |
 |
Genetron Holdings Limited
GTH
|
48.5 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
1.15 B | $ 72.79 | -0.34 % | $ 28.1 B | USA |
 |
CareDx, Inc
CDNA
|
17.9 M | $ 20.29 | -1.27 % | $ 1.09 B | USA |
 |
Celcuity
CELC
|
69.2 K | $ 111.76 | 2.14 % | $ 4.41 B | USA |
 |
DarioHealth Corp.
DRIO
|
25.8 M | $ 10.74 | 7.19 % | $ 305 M | Israel |
 |
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
2.26 M | $ 26.0 | -0.76 % | $ 786 M | USA |
 |
Lantheus Holdings
LNTH
|
225 M | $ 66.88 | -0.07 % | $ 4.63 B | USA |
 |
Medpace Holdings
MEDP
|
73.8 M | $ 585.24 | 0.47 % | $ 18.1 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | USA |
 |
IDEXX Laboratories
IDXX
|
630 M | $ 636.25 | -5.1 % | $ 52.5 B | USA |
 |
NeoGenomics
NEO
|
434 M | $ 12.25 | 1.53 % | $ 1.55 B | USA |
 |
Illumina
ILMN
|
2.04 B | $ 140.65 | -2.87 % | $ 22.4 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.58 B | - | - | $ 10.6 B |  Niderland |
 |
National Research Corporation
NRC
|
39.6 M | $ 21.87 | 7.5 % | $ 537 M | USA |
 |
IQVIA Holdings
IQV
|
13 B | $ 230.93 | 0.34 % | $ 41.9 B | USA |
 |
Charles River Laboratories International
CRL
|
2.35 B | $ 212.06 | 0.7 % | $ 10.9 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.08 B | $ 28.84 | 0.47 % | $ 20 B | Niderland |
 |
Precipio
PRPO
|
1.9 M | $ 24.75 | 0.9 % | $ 32.1 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.17 B | $ 184.48 | -1.33 % | $ 20.5 B | USA |
|
Biodesix
BDSX
|
62.1 M | $ 10.24 | 0.69 % | $ 1.33 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 269.19 | -0.86 % | $ 22.6 B | USA |
 |
ICON Public Limited Company
ICLR
|
461 M | $ 176.3 | -2.19 % | $ 14.5 B |  Irlanda |
 |
Agilent Technologies
A
|
3.29 B | $ 134.7 | 0.62 % | $ 40.9 B | USA |
 |
Biomerica
BMRA
|
1.57 M | $ 2.39 | 0.63 % | $ 5.49 M | USA |
 |
OpGen
OPGN
|
21.2 M | - | -16.95 % | $ 1.54 M | USA |
 |
Bioventus
BVS
|
238 M | $ 8.23 | 3.78 % | $ 516 M | USA |